RSV prevention shot tested on 816 chinese babies
NCT ID NCT07382219
Summary
This study looked at how well a preventive medication called nirsevimab works in real-world settings to protect infants from RSV and other respiratory infections. Researchers compared 816 Chinese infants who received the shot with those who didn't during the RSV season. They tracked hospitalizations and infections over six months using medical records from seven major hospitals.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Children's Hospital
Beijing, 100045, China
-
Beijing Luhe Hospital
Beijing, 101149, China
-
Inner Mongolia Maternity and Child Health Care Hospital
Hohhot, Inner Mongolia, 010000, China
-
Peking University Third Hospital
Beijing, 100191, China
-
Shenzhen Maternity & Child Healthcare Hospital
Shenzhen, 518000, China
-
Women and Children's Hospital
Qingdao, Shandong, 266000, China
-
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, 200092, China
Conditions
Explore the condition pages connected to this study.